Muraglitazar

• Description :

  Muraglitazar (BMS-298585) is a PPAR α/γ dual agonist for the treatment of type 2 diabetes and associated dyslipidemia. Muraglitazar shows potent activity in vitro at human PPARα and PPARγ with EC50 of 320 nM and 110 nM respectively.

• CAS Number :

  331741-94-7

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  516.54

• Molecular Formula :

  C29H28N2O7

• Notes :

  Research use only, not for human use.

• Receptor :

  PPAR